Northwestern Mutual Wealth Management
STOK icon

Northwestern Mutual Wealth Management’s Stoke Therapeutics STOK Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-119
Closed -$1.46K – 3874
2024
Q3 		$1.46K Buy
+119
New +$1.69K ﹤0.01% 3182
2022
Q1 		– Sell
-750
Closed -$18K – 3383
2021
Q4 		$18K Buy
+750
New +$17.9K ﹤0.01% 2383

Other funds holding STOK

ST
Skorpios Trust Limassol, Cyprus $53.2M AUM 90.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Northwestern Mutual Wealth Management's STOK Position: Q4 2024 in Review

Northwestern Mutual Wealth Management sold out of Stoke Therapeutics (STOK) in Q4 2024, closing a stake of 119 shares — an estimated $1.46K sold.

Northwestern Mutual Wealth Management first reported a position in STOK in Q4 2021 and held it in 2 quarters. The position peaked at $18K in Q4 2021. 130 funds tracked by Wall St. Rank hold STOK as of Q4 2024.

  • Northwestern Mutual Wealth Management reported no remaining Stoke Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 119 Stoke Therapeutics shares in Q4 2024, an estimated $1.46K.
  • Northwestern Mutual Wealth Management first reported a position in Stoke Therapeutics in Q4 2021 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Stoke Therapeutics position peaked at $18K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.